The Drug Regulatory Authority of Pakistan has developed and released an animated video in the Sindhi language aimed at educating both patients and healthcare professionals about how to report suspected adverse events linked to medicines, extending the reach of the country’s pharmacovigilance awareness efforts into one of its most linguistically distinct and populous provinces. The video was produced by the National Pharmacovigilance Centre of the Drug Regulatory Authority of Pakistan and explains in accessible terms the different channels through which adverse drug events can be reported, both to the Provincial Pharmacovigilance Centre in Sindh and to the National Pharmacovigilance Centre at the federal level.
The decision to develop the video in Sindhi rather than solely in Urdu or English reflects a deliberate recognition that effective pharmacovigilance reporting requires communication in the languages that communities actually use in their daily lives, particularly in healthcare contexts where language barriers can be a significant obstacle to participation. Sindh is home to tens of millions of Sindhi speakers, a large proportion of whom interact with the healthcare system in their native language, and the availability of clear, accessible information about adverse drug reporting in Sindhi removes a practical barrier that has previously limited engagement from this demographic with formal medicine safety reporting mechanisms.
Pharmacovigilance, the ongoing monitoring and reporting of drug safety after medicines have reached the market, is an essential component of a functional national drug safety system. Adverse event data collected from patients and healthcare professionals in the field provides regulators with the information needed to identify unexpected side effects, assess whether risks are emerging at scale, and take corrective action including label updates, safety communications, or market withdrawals where necessary. The more representative and geographically diverse the reporting base, the more reliable the safety signal that emerges from the data, making community-level outreach in regional languages a direct contributor to the quality of pharmacovigilance outcomes at a national level.
The Drug Regulatory Authority of Pakistan urged patients and healthcare professionals across Sindh to watch the animated video, familiarise themselves with the reporting process it outlines, and actively participate in the medicine safety reporting system. The initiative forms part of a broader pharmacovigilance awareness drive, and the use of animation as a format makes the content accessible to audiences with varying levels of health literacy, addressing both language and educational barriers simultaneously in a format that can be shared through mobile devices and social platforms widely used across Sindh’s urban and rural communities.
Follow the SPIN IDG WhatsApp Channel for updates across the Smart Pakistan Insights Network covering all of Pakistan’s technology ecosystem.
